Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator.
Enforcement Report - Week of April 17, 2024
FDA hits Natco with warning letter over India facility, suspends product shipments to US
Natco Pharma Receives FDA Warning Letter
Leading generic drug makers Lupin, Glenmark, and Natco Pharma are recalling products in the American market for manufacturing issues, according to the US health regulator.
Natco Pharma gets USFDA warning letter for Kothur plant
Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant.
Enforcement Report - Week of February 14, 2024
Cellogen Therapeutics Private Limited, a Delhi based biotech startup promoted by Dr. Gaurav Kharya, Director, Centre for Bone Marrow Transplant & Cellular Therapy, Indraprastha Apollo Hospital, Delhi has raised around US$ 2 million from NATCO Pharma Limited. Cellogen is primarily involved in two R&D programs involving cell and gene therapy solutions.
Natco Pharma Completes Transition of DASH Pharmaceuticals into Natco Pharma